| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hemoglobinuria, Paroxysmal | 11 | 2019 | 116 | 1.90 | Why? |
| Anemia, Aplastic | 5 | 2019 | 167 | 0.82 | Why? |
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2018 | 76 | 0.73 | Why? |
| Adenosine Triphosphate | 1 | 2018 | 294 | 0.61 | Why? |
| Immune Tolerance | 1 | 2018 | 608 | 0.52 | Why? |
| Blood Donors | 4 | 2021 | 2956 | 0.50 | Why? |
| Antilymphocyte Serum | 2 | 2019 | 80 | 0.37 | Why? |
| Complement Activation | 3 | 2019 | 949 | 0.34 | Why? |
| Cytomegalovirus Infections | 3 | 2018 | 667 | 0.33 | Why? |
| Thoracic Injuries | 2 | 2017 | 63 | 0.33 | Why? |
| Hematopoietic Stem Cell Transplantation | 5 | 2018 | 2426 | 0.32 | Why? |
| Unrelated Donors | 2 | 2017 | 187 | 0.31 | Why? |
| Complement Inactivating Agents | 2 | 2019 | 254 | 0.31 | Why? |
| Cytomegalovirus | 2 | 2018 | 600 | 0.25 | Why? |
| Hemolysis | 4 | 2018 | 283 | 0.24 | Why? |
| Bone Regeneration | 2 | 2018 | 35 | 0.24 | Why? |
| Antibodies, Monoclonal, Humanized | 6 | 2019 | 9335 | 0.23 | Why? |
| Rh-Hr Blood-Group System | 1 | 2021 | 55 | 0.22 | Why? |
| Antibodies, Neutralizing | 6 | 2021 | 25288 | 0.22 | Why? |
| Leukemia, Myeloid, Acute | 2 | 2017 | 676 | 0.21 | Why? |
| Complement Factor H | 1 | 2019 | 83 | 0.20 | Why? |
| Duffy Blood-Group System | 1 | 2019 | 4 | 0.20 | Why? |
| Antibodies, Viral | 10 | 2021 | 51949 | 0.20 | Why? |
| Peripheral Blood Stem Cells | 1 | 2019 | 21 | 0.20 | Why? |
| Flow Cytometry | 2 | 2018 | 2393 | 0.19 | Why? |
| HIV Long Terminal Repeat | 1 | 2018 | 16 | 0.19 | Why? |
| Complement C5 | 2 | 2018 | 139 | 0.19 | Why? |
| Immunization, Passive | 5 | 2021 | 10067 | 0.19 | Why? |
| Alveolar Bone Loss | 1 | 2018 | 19 | 0.19 | Why? |
| Apyrase | 1 | 2018 | 39 | 0.19 | Why? |
| ADP-ribosyl Cyclase | 1 | 2018 | 2 | 0.19 | Why? |
| Culture Media, Conditioned | 1 | 2018 | 66 | 0.19 | Why? |
| Bone Transplantation | 1 | 2018 | 38 | 0.19 | Why? |
| Hematopoietic Stem Cell Mobilization | 1 | 2019 | 73 | 0.19 | Why? |
| Gap Junctions | 1 | 2017 | 18 | 0.18 | Why? |
| Connexin 43 | 1 | 2017 | 37 | 0.18 | Why? |
| Lyme Disease | 1 | 2019 | 102 | 0.18 | Why? |
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2018 | 95 | 0.18 | Why? |
| Cytomegalovirus Vaccines | 1 | 2017 | 6 | 0.18 | Why? |
| Transplantation, Heterologous | 1 | 2017 | 77 | 0.17 | Why? |
| Kynurenine | 1 | 2018 | 140 | 0.17 | Why? |
| Cyclosporine | 2 | 2019 | 449 | 0.17 | Why? |
| Isoantibodies | 1 | 2018 | 134 | 0.17 | Why? |
| Platelet-Rich Plasma | 1 | 2018 | 91 | 0.17 | Why? |
| Histocompatibility | 1 | 2017 | 53 | 0.16 | Why? |
| Dental Implants | 1 | 2018 | 101 | 0.16 | Why? |
| Tryptophan | 1 | 2018 | 218 | 0.16 | Why? |
| Antigens | 1 | 2019 | 267 | 0.16 | Why? |
| Mesenchymal Stem Cell Transplantation | 2 | 2018 | 1322 | 0.16 | Why? |
| Tissue Donors | 3 | 2021 | 1679 | 0.16 | Why? |
| Erythrocytes | 2 | 2018 | 617 | 0.15 | Why? |
| Receptors, KIR | 1 | 2017 | 167 | 0.15 | Why? |
| Anemia, Hemolytic, Autoimmune | 1 | 2018 | 199 | 0.15 | Why? |
| Wounds, Nonpenetrating | 1 | 2017 | 157 | 0.15 | Why? |
| Nuclear Proteins | 1 | 2017 | 321 | 0.14 | Why? |
| Receptors, Cell Surface | 1 | 2019 | 586 | 0.14 | Why? |
| Cell- and Tissue-Based Therapy | 1 | 2018 | 422 | 0.13 | Why? |
| Quality of Life | 5 | 2019 | 9820 | 0.13 | Why? |
| Cells, Cultured | 3 | 2018 | 5835 | 0.12 | Why? |
| Histocompatibility Antigens Class I | 1 | 2017 | 624 | 0.12 | Why? |
| Lymphocyte Activation | 2 | 2021 | 2742 | 0.12 | Why? |
| Antigens, CD | 1 | 2018 | 984 | 0.12 | Why? |
| Age of Onset | 1 | 2014 | 557 | 0.12 | Why? |
| Hematologic Diseases | 1 | 2018 | 614 | 0.11 | Why? |
| Kidney Transplantation | 2 | 2021 | 5397 | 0.11 | Why? |
| Cell Proliferation | 1 | 2018 | 1973 | 0.11 | Why? |
| Transplantation, Homologous | 3 | 2018 | 757 | 0.11 | Why? |
| Neutralization Tests | 2 | 2021 | 6698 | 0.10 | Why? |
| Registries | 4 | 2018 | 12327 | 0.10 | Why? |
| Immunomodulation | 1 | 2018 | 1472 | 0.10 | Why? |
| Viral Matrix Proteins | 1 | 2017 | 1243 | 0.09 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2019 | 3607 | 0.09 | Why? |
| Male | 24 | 2021 | 367725 | 0.09 | Why? |
| Reagent Kits, Diagnostic | 1 | 2018 | 2149 | 0.09 | Why? |
| Immune Evasion | 1 | 2018 | 2081 | 0.09 | Why? |
| Blood Transfusion | 1 | 2017 | 1399 | 0.09 | Why? |
| Granulocyte Colony-Stimulating Factor | 2 | 2019 | 264 | 0.09 | Why? |
| Adjuvants, Immunologic | 1 | 2017 | 1709 | 0.08 | Why? |
| Autoantibodies | 1 | 2018 | 2094 | 0.08 | Why? |
| Adolescent | 10 | 2021 | 86841 | 0.08 | Why? |
| Humans | 39 | 2021 | 930598 | 0.08 | Why? |
| Female | 21 | 2021 | 380317 | 0.08 | Why? |
| Young Adult | 10 | 2021 | 93724 | 0.08 | Why? |
| Blood Platelets | 1 | 2018 | 1704 | 0.08 | Why? |
| Histocompatibility Testing | 2 | 2017 | 219 | 0.08 | Why? |
| Phosphoproteins | 1 | 2017 | 4346 | 0.08 | Why? |
| Middle Aged | 19 | 2021 | 270681 | 0.08 | Why? |
| L-Lactate Dehydrogenase | 3 | 2018 | 1995 | 0.08 | Why? |
| Aged | 16 | 2021 | 215776 | 0.08 | Why? |
| Rats, Wistar | 2 | 2017 | 621 | 0.08 | Why? |
| Transplantation Conditioning | 2 | 2018 | 323 | 0.08 | Why? |
| Myocardium | 1 | 2017 | 2323 | 0.07 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.07 | Why? |
| Adult | 17 | 2021 | 244371 | 0.07 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.07 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.07 | Why? |
| Immunocompromised Host | 1 | 2021 | 5150 | 0.07 | Why? |
| Internationality | 1 | 2017 | 3297 | 0.07 | Why? |
| Wound Healing | 2 | 2018 | 424 | 0.07 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.07 | Why? |
| Treatment Outcome | 10 | 2021 | 51732 | 0.07 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.06 | Why? |
| Hematologic Neoplasms | 1 | 2017 | 2105 | 0.06 | Why? |
| HIV-1 | 1 | 2018 | 3365 | 0.06 | Why? |
| Public Health Surveillance | 1 | 2017 | 3129 | 0.06 | Why? |
| Employment | 1 | 2014 | 1754 | 0.06 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.06 | Why? |
| Alleles | 2 | 2019 | 1557 | 0.06 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2017 | 4545 | 0.06 | Why? |
| Transplantation Immunology | 1 | 2021 | 99 | 0.06 | Why? |
| Monitoring, Immunologic | 1 | 2021 | 153 | 0.05 | Why? |
| Complement C3b Inactivator Proteins | 1 | 2019 | 11 | 0.05 | Why? |
| Surveys and Questionnaires | 2 | 2019 | 43792 | 0.05 | Why? |
| Solubility | 1 | 2021 | 382 | 0.05 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2017 | 5837 | 0.05 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.05 | Why? |
| Kaplan-Meier Estimate | 2 | 2021 | 4260 | 0.05 | Why? |
| Cholinesterases | 1 | 2019 | 48 | 0.05 | Why? |
| Mortality | 1 | 2017 | 7132 | 0.05 | Why? |
| Hydroxyapatites | 1 | 2018 | 3 | 0.05 | Why? |
| Blood Group Incompatibility | 1 | 2019 | 44 | 0.05 | Why? |
| High-Throughput Screening Assays | 2 | 2018 | 1783 | 0.05 | Why? |
| Red Cross | 1 | 2018 | 33 | 0.05 | Why? |
| Antigens, CD34 | 1 | 2019 | 125 | 0.05 | Why? |
| Collagen Type III | 1 | 2018 | 12 | 0.05 | Why? |
| Drug Evaluation | 1 | 2018 | 100 | 0.05 | Why? |
| Viral Plaque Assay | 1 | 2020 | 381 | 0.05 | Why? |
| Erythrocyte Count | 1 | 2019 | 137 | 0.05 | Why? |
| Cell Shape | 1 | 2017 | 57 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2018 | 8041 | 0.05 | Why? |
| Granulocytes | 1 | 2019 | 140 | 0.05 | Why? |
| Tendons | 1 | 2018 | 43 | 0.05 | Why? |
| Extracellular Space | 1 | 2017 | 26 | 0.04 | Why? |
| Cross-Over Studies | 1 | 2021 | 867 | 0.04 | Why? |
| Collagen Type I | 1 | 2018 | 56 | 0.04 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2018 | 13720 | 0.04 | Why? |
| Potassium Channels, Inwardly Rectifying | 1 | 2017 | 29 | 0.04 | Why? |
| Osteogenesis | 1 | 2018 | 95 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2018 | 11041 | 0.04 | Why? |
| Protein Isoforms | 1 | 2019 | 347 | 0.04 | Why? |
| Matrix Metalloproteinase 1 | 1 | 2018 | 60 | 0.04 | Why? |
| Complement C1 | 1 | 2017 | 12 | 0.04 | Why? |
| Adsorption | 1 | 2018 | 261 | 0.04 | Why? |
| Organic Chemicals | 1 | 2017 | 90 | 0.04 | Why? |
| Complement C3b | 1 | 2016 | 26 | 0.04 | Why? |
| Neovascularization, Physiologic | 1 | 2018 | 160 | 0.04 | Why? |
| Gene Expression | 2 | 2018 | 3332 | 0.04 | Why? |
| Cell Count | 1 | 2017 | 228 | 0.04 | Why? |
| Bone Marrow Cells | 1 | 2018 | 186 | 0.04 | Why? |
| Transplantation, Autologous | 1 | 2018 | 364 | 0.04 | Why? |
| Complement Pathway, Alternative | 1 | 2016 | 35 | 0.04 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.04 | Why? |
| Genes, Reporter | 1 | 2018 | 472 | 0.04 | Why? |
| Membrane Fusion | 1 | 2021 | 713 | 0.04 | Why? |
| GPI-Linked Proteins | 1 | 2018 | 317 | 0.04 | Why? |
| Immunity, Cellular | 2 | 2021 | 3614 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Tissue Engineering | 1 | 2018 | 190 | 0.04 | Why? |
| Immunity, Humoral | 2 | 2021 | 4849 | 0.04 | Why? |
| Genetic Engineering | 1 | 2018 | 325 | 0.04 | Why? |
| Bone Marrow | 1 | 2019 | 492 | 0.04 | Why? |
| Genotype | 2 | 2019 | 4697 | 0.04 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.04 | Why? |
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 245 | 0.04 | Why? |
| Culture Media | 1 | 2018 | 366 | 0.04 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.04 | Why? |
| Histones | 1 | 2017 | 371 | 0.04 | Why? |
| Erythrocyte Transfusion | 1 | 2018 | 386 | 0.04 | Why? |
| Bone Marrow Transplantation | 1 | 2017 | 343 | 0.03 | Why? |
| Drug Resistance, Viral | 1 | 2021 | 1083 | 0.03 | Why? |
| Renal Dialysis | 2 | 2021 | 4358 | 0.03 | Why? |
| Survival Analysis | 2 | 2018 | 7592 | 0.03 | Why? |
| Child, Preschool | 2 | 2018 | 36283 | 0.03 | Why? |
| Immunization, Secondary | 1 | 2021 | 1649 | 0.03 | Why? |
| Blood Safety | 1 | 2018 | 459 | 0.03 | Why? |
| Germany | 2 | 2018 | 9196 | 0.03 | Why? |
| Europe | 2 | 2021 | 12702 | 0.03 | Why? |
| Platelet Count | 1 | 2019 | 1381 | 0.03 | Why? |
| Hemoglobins | 1 | 2018 | 958 | 0.03 | Why? |
| Animals | 5 | 2021 | 78931 | 0.03 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.03 | Why? |
| Cytokines | 3 | 2021 | 15010 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2021 | 3395 | 0.03 | Why? |
| Cell Survival | 1 | 2018 | 1581 | 0.03 | Why? |
| Immunosuppressive Agents | 2 | 2021 | 6331 | 0.03 | Why? |
| Ligands | 1 | 2017 | 1300 | 0.03 | Why? |
| Donor Selection | 1 | 2018 | 804 | 0.03 | Why? |
| Mice, Transgenic | 1 | 2018 | 2739 | 0.03 | Why? |
| False Negative Reactions | 1 | 2018 | 1785 | 0.03 | Why? |
| Neoplasm Staging | 1 | 2018 | 1999 | 0.03 | Why? |
| Virus Internalization | 2 | 2021 | 7921 | 0.03 | Why? |
| HLA Antigens | 1 | 2017 | 830 | 0.03 | Why? |
| RNA, Viral | 1 | 2018 | 32276 | 0.03 | Why? |
| Asia | 1 | 2018 | 2399 | 0.03 | Why? |
| T-Lymphocyte Subsets | 1 | 2018 | 1387 | 0.03 | Why? |
| Prospective Studies | 3 | 2021 | 43301 | 0.03 | Why? |
| Prognosis | 3 | 2018 | 32490 | 0.03 | Why? |
| Rats | 1 | 2017 | 2764 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2021 | 3567 | 0.02 | Why? |
| Immunologic Memory | 1 | 2021 | 3362 | 0.02 | Why? |
| Heart Ventricles | 1 | 2017 | 1139 | 0.02 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 2309 | 0.02 | Why? |
| Child | 2 | 2018 | 70012 | 0.02 | Why? |
| Hematopoiesis | 1 | 2009 | 168 | 0.02 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.02 | Why? |
| Apoptosis | 1 | 2017 | 2335 | 0.02 | Why? |
| Models, Molecular | 1 | 2021 | 7616 | 0.02 | Why? |
| Killer Cells, Natural | 1 | 2017 | 2093 | 0.02 | Why? |
| Cross-Sectional Studies | 1 | 2014 | 53120 | 0.02 | Why? |
| Immunity | 1 | 2017 | 2651 | 0.02 | Why? |
| Thromboembolism | 1 | 2018 | 2101 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.02 | Why? |
| Cell Line | 1 | 2021 | 12040 | 0.02 | Why? |
| Serine Endopeptidases | 1 | 2021 | 4606 | 0.02 | Why? |
| Transplant Recipients | 1 | 2021 | 4982 | 0.02 | Why? |
| HEK293 Cells | 1 | 2018 | 8394 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2019 | 6740 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| Hospitalization | 1 | 2014 | 54280 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2019 | 11304 | 0.01 | Why? |
| Retrospective Studies | 3 | 2018 | 105322 | 0.01 | Why? |
| Sex Factors | 1 | 2019 | 11014 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2019 | 8495 | 0.01 | Why? |
| Antigens, Viral | 1 | 2018 | 6298 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2019 | 17020 | 0.01 | Why? |
| Disease Progression | 1 | 2019 | 13580 | 0.01 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Mice | 1 | 2018 | 21357 | 0.01 | Why? |
| Risk Factors | 2 | 2018 | 71621 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.01 | Why? |
| Infant | 1 | 2018 | 30274 | 0.01 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.01 | Why? |
| Survival Rate | 1 | 2009 | 9206 | 0.01 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Lung | 1 | 2017 | 31049 | 0.01 | Why? |
| Pandemics | 2 | 2021 | 389249 | 0.00 | Why? |